https://orcid.org/0000-0002-9160-6846
References
- Abraham I, Lee KKC, Gregg M. Journal of medical economics in review: the best of 2021. J Med Econ. 2022;25(1):282–286.
- Ohno S, Chen Y, Sakamaki H, et al. Burden of caring for Alzheimer's disease or dementia patients in Japan, the US, and EU: results from the national health and wellness survey: a cross-sectional survey. J Med Econ. 2021;24(1):266–278.
- Pennington B. Inclusion of carer Health-Related quality of life in national institute for health and care excellence appraisals. Value Health. 2020;23(10):1349–1357.
- Dawoud D, Lamb A, Moore A, et al. Capturing what matters: updating NICE methods guidance on measuring and valuing health. Qual Life Res. 2022;31:2167–2173.
- National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual; 2022, January 31 [cited 2022 Mar 16]. Available from: https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation.
- Moss AJ, Jackson Hall W, Cannom DS, IIIMADIT-CRT Trial Investigators, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–1338.
- Jakovljevic M, Wu W, Merrick J, et al. Asian innovation in pharmaceutical and medical device industry–beyond tomorrow. J Med Econ. 2021;24(sup1):42–50.
- Jakovljevic M, Liu Y, Cerda A, et al. The global South political economy of health financing and spending landscape–history and presence. J Med Econ. 2021;24(sup1):25–33.
- WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem; 2020. Available from: https://apps.who.int/iris/handle/10665/336583.
- Messoudi W, Elmahi T, Nejjari C, et al. Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis. J Med Econ. 2019;22(11):1153–1159.
- Falcaro M, Castañon A, Ndlela B, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398(10316):2084–2092.
- Atieno OM, Opanga S, Martin A, et al. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. J Med Econ. 2018;21(9):878–887.
- Whitty JA, de Bekker-Grob EW, Cook NS, et al. Patient preferences in the medical product lifecycle. Patient. 2020;13(1):7–10.
- Phisalprapa P, Supakankunti S, Chaiyakunapruk N. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand. J Med Econ. 2019;22(12):1351–1361.
- Cheung KL, Hors-Fraile S, de Vries H. How to use the integrated-change model to design digital health programs. Digital Health, Elsevier; 2021. p. 143–157.
- ISPOR Health Science Policy Council. 2022-2023 Top 10 HEOR Trends. An ISPOR White Paper. 2022. Available from: https://www.ispor.org/heor-resources/good-practices/article/ispor-2022-2023-top-10-heor-trends.
- Belen O, Concato J, Kraus S. FDA Approval Demonstrates the Role of Real-World Evidence in Regulatory Decision-Making on Drug Effectiveness2021.
- Miyazaki C, Sruamsiri R, Mahlich J, et al. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. J Med Econ. 2020;23(7):786–799.
- Shen L, Li Q, Wang W, et al. Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China. J Med Econ. 2020;23(5):456–463.
- Lees N. The Brandt Line after forty years: the more North–South relations change, the more they stay the same?; 2020 [cited 2022 April]. https://www.bisa.ac.uk/articles/brandt-line-after-forty-years-more-north-south-relations-change-more-they-stay-same.
- Agnus Maddison Project; 2020 [cited 2022 April]. Available from: https://www.rug.nl/ggdc/historicaldevelopment/maddison/?lang=en.
- OECD data. Gross domestic product 2022; 2022 [cited 2022 April]. Available from: https://data.oecd.org/gdp/gross-domestic-product-gdp.htm#indicator-chart.
- Bredenkamp C, Evans T, Lagrada L, et al. Emerging challenges in implementing universal health coverage in asia. Soc Sci Med. 2015;145:243–248.
- Sijsterman E, Cheung KL, Goossens AJM, et al. A discrete choice experiment to assess patients’ preferences for HIV treatment in the urban population in Colombia. J Med Econ. 2020;23(8):812–818.